These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 33258263)
1. Active Vitamin D Lee PC; Hsieh YC; Huo TI; Yang UC; Lin CH; Li CP; Huang YH; Hou MC; Lin HC; Lee KC Mol Nutr Food Res; 2021 Feb; 65(3):e2000937. PubMed ID: 33258263 [TBL] [Abstract][Full Text] [Related]
2. Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl Xu H; Xiong J; Xu J; Li S; Zhou Y; Chen D; Cai X; Ping J; Deng M; Chen J Dig Dis Sci; 2017 Oct; 62(10):2801-2811. PubMed ID: 28815345 [TBL] [Abstract][Full Text] [Related]
3. Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats. Úbeda M; Lario M; Muñoz L; Borrero MJ; Rodríguez-Serrano M; Sánchez-Díaz AM; Del Campo R; Lledó L; Pastor Ó; García-Bermejo L; Díaz D; Álvarez-Mon M; Albillos A J Hepatol; 2016 May; 64(5):1049-1057. PubMed ID: 26723896 [TBL] [Abstract][Full Text] [Related]
4. Pregnane X receptor activation by its natural ligand Ginkgolide-A improves tight junction proteins expression and attenuates bacterial translocation in cirrhosis. Mohandas S; Vairappan B Chem Biol Interact; 2020 Jan; 315():108891. PubMed ID: 31697926 [TBL] [Abstract][Full Text] [Related]
5. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis. Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391 [TBL] [Abstract][Full Text] [Related]
6. Oral administration of liquid iron preparation containing excess iron induces intestine and liver injury, impairs intestinal barrier function and alters the gut microbiota in rats. Fang S; Zhuo Z; Yu X; Wang H; Feng J J Trace Elem Med Biol; 2018 May; 47():12-20. PubMed ID: 29544798 [TBL] [Abstract][Full Text] [Related]
7. Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model. Su YB; Li TH; Huang CC; Tsai HC; Huang SF; Hsieh YC; Yang YY; Huang YH; Hou MC; Lin HC PLoS One; 2018; 13(4):e0194867. PubMed ID: 29684027 [TBL] [Abstract][Full Text] [Related]
8. Comparative portal hypotensive effects as propranolol of vitamin D₃ treatment by decreasing intrahepatic resistance in cirrhotic rats. Lee PC; Yang YY; Lee WP; Lee KC; Hsieh YC; Lee TY; Lin HC J Gastroenterol Hepatol; 2015 Mar; 30(3):628-37. PubMed ID: 25187428 [TBL] [Abstract][Full Text] [Related]
9. [Effects of vitamin D Liu XZ; You B; Zhang YL; Yang ZC; Chen P; Shi YL; Chen Y; Chen YJ; Chen J; Peng YZ Zhonghua Shao Shang Za Zhi; 2019 Apr; 35(4):284-291. PubMed ID: 31060176 [No Abstract] [Full Text] [Related]
10. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis. Sánchez E; Casafont F; Guerra A; de Benito I; Pons-Romero F Rev Esp Enferm Dig; 2005 Nov; 97(11):805-14. PubMed ID: 16438624 [TBL] [Abstract][Full Text] [Related]
11. Celecoxib attenuates hepatocyte apoptosis by inhibiting endoplasmic reticulum stress in thioacetamide-induced cirrhotic rats. Su W; Tai Y; Tang SH; Ye YT; Zhao C; Gao JH; Tuo BG; Tang CW World J Gastroenterol; 2020 Jul; 26(28):4094-4107. PubMed ID: 32821072 [TBL] [Abstract][Full Text] [Related]
12. Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis. Zhang SC; Wang W; Ren WY; He BM; Zhou K; Zhu WN World J Gastroenterol; 2003 Mar; 9(3):534-8. PubMed ID: 12632513 [TBL] [Abstract][Full Text] [Related]
13. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis. Sorribas M; Jakob MO; Yilmaz B; Li H; Stutz D; Noser Y; de Gottardi A; Moghadamrad S; Hassan M; Albillos A; Francés R; Juanola O; Spadoni I; Rescigno M; Wiest R J Hepatol; 2019 Dec; 71(6):1126-1140. PubMed ID: 31295531 [TBL] [Abstract][Full Text] [Related]
14. IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats. Zhao TY; Su LP; Ma CY; Zhai XH; Duan ZJ; Zhu Y; Zhao G; Li CY; Wang LX; Yang D BMC Gastroenterol; 2015 Jul; 15():77. PubMed ID: 26152281 [TBL] [Abstract][Full Text] [Related]
15. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model. Kanwal S; Joseph TP; Owusu L; Xiaomeng R; Meiqi L; Yi X Nutrients; 2018 Jul; 10(8):. PubMed ID: 30065236 [TBL] [Abstract][Full Text] [Related]
16. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications. Ponziani FR; Gerardi V; Pecere S; D'Aversa F; Lopetuso L; Zocco MA; Pompili M; Gasbarrini A World J Gastroenterol; 2015 Nov; 21(43):12322-33. PubMed ID: 26604640 [TBL] [Abstract][Full Text] [Related]
17. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Pérez-Paramo M; Muñoz J; Albillos A; Freile I; Portero F; Santos M; Ortiz-Berrocal J Hepatology; 2000 Jan; 31(1):43-8. PubMed ID: 10613726 [TBL] [Abstract][Full Text] [Related]
18. Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. Chiva M; Soriano G; Rochat I; Peralta C; Rochat F; Llovet T; Mirelis B; Schiffrin EJ; Guarner C; Balanzó J J Hepatol; 2002 Oct; 37(4):456-62. PubMed ID: 12217598 [TBL] [Abstract][Full Text] [Related]
19. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Pardo A; Bartolí R; Lorenzo-Zúñiga V; Planas R; Viñado B; Riba J; Cabré E; Santos J; Luque T; Ausina V; Gassull MA Hepatology; 2000 Apr; 31(4):858-63. PubMed ID: 10733540 [TBL] [Abstract][Full Text] [Related]
20. Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in D-galactosamine-treated rats. Li Y; Lv L; Ye J; Fang D; Shi D; Wu W; Wang Q; Wu J; Yang L; Bian X; Jiang X; Jiang H; Yan R; Peng C; Li L Appl Microbiol Biotechnol; 2019 Jan; 103(1):375-393. PubMed ID: 30345482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]